1. Deficiency of the purinergic receptor P2X4 limits atherosclerosis in mice. (25th November 2020) Authors: Koenig, S; Peikert, A; Merz, J; Rofa, K; Schaefer, I; Dimanski, D; Karnbrock, L; Von Garlen, S; Aleid, R; Bulatova, K; Hoppe, N; Bode, C; Zirlik, A; Stachon, P Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome of metabolic syndrome in mice. (25th November 2020) Authors: Merz, J; Rofa, K; Karnbrock, L; Von Garlen, S; Dimanski, D; Koenig, S; Bulatova, K; Schaefer, I; Peikert, A; Albrecht, P; Hoppe, N; Bode, C; Zirlik, A; Stachon, P Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P2843Knockout of purinergic receptor Y6 (P2Y6) leads to cardiomyopathy in mice. (28th August 2018) Authors: Ahmed, I; Merz, J; Rofa, K; Dufner, B; Schickmeier, J; Hoppe, N; Hilgendorf, I; Bode, C; Zirlik, A; Stachon, P Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗